Adamas Announces FDA Approval of GOCOVRI(TM) as First and Only Medication for the Treatment of Dyskinesia in Parkinson's Disease Patients
Stock Information for Adamas Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.